vimarsana.com
Home
Live Updates
Soleno Therapeutics Announces Oral Presentation featuring DC
Soleno Therapeutics Announces Oral Presentation featuring DC
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
Soleno Therapeutics, Inc. announced that data from the randomized withdrawal period of Study C602 of DCCR extended-release tablets in Prader-Willi Syndrome will be featured in an oral presentation...
Related Keywords
Massachusetts ,
United States ,
Boston ,
,
Soleno Therapeutics Inc ,
Prader Willi Syndrome Association United States ,
Meeting Of The Endocrine Society ,
Foundation For Prader Willi Research ,
Soleno Therapeutics ,
Prader Willi Syndrome ,
Annual Meeting ,
Endocrine Society ,
Prader Willi Research ,
Orphan Drug Designation ,
Fast Track ,
Breakthrough Designations ,